Navigation Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-154
Closed -$18K 27
2022
Q3
$18K Hold
154
1.94% 9
2022
Q2
$22K Hold
154
2.44% 6
2022
Q1
$27K Hold
154
0.25% 9
2021
Q4
$39K Hold
154
0.04% 23
2021
Q3
$52K Hold
154
0.34% 11
2021
Q2
$36K Buy
+154
New +$27.5K 0.03% 28

Other funds holding MRNA

Navigation Wealth Management's MRNA Position: Q4 2022 in Review

Navigation Wealth Management sold out of Moderna (MRNA) in Q4 2022, closing a stake of 154 shares — an estimated $18K sold.

Navigation Wealth Management first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $52K in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Navigation Wealth Management reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Navigation Wealth Management sold 154 Moderna shares in Q4 2022, an estimated $18K.
  • Navigation Wealth Management first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
  • Navigation Wealth Management's Moderna position peaked at $52K in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Navigation Wealth Management's 13F filing for Q4 2022, filed 6 Jan 2023.